Paratek Pharma Inc (PRTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,373 | 80,492 | 106,048 | 102,626 | 47,253 |
| Marketable Securities | N/A | 15,107 | 20,005 | 113,077 | 203,364 |
| Receivables | 78,038 | 33,117 | 15,733 | 9,583 | 249 |
| Inventories | 16,565 | 11,020 | 14,555 | 11,579 | 598 |
| TOTAL | $136,842 | $152,100 | $164,117 | $243,354 | $255,243 |
| Non-Current Assets | |||||
| PPE Net | 616 | 794 | 964 | 1,227 | 1,173 |
| Intangibles | 829 | 829 | 829 | 829 | 829 |
| Other Non-Current Assets | 34,251 | 30,146 | 10,943 | 5,669 | 42,947 |
| TOTAL | $35,696 | $31,769 | $12,736 | $7,725 | $44,949 |
| Total Assets | $172,538 | $183,869 | $176,853 | $251,079 | $300,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,308 | 5,394 | 1,813 | 4,116 | 2,090 |
| Accrued Expenses | 31,210 | 23,446 | 20,826 | 16,696 | N/A |
| Other current liabilities | 870 | 2,457 | 1,314 | 3,388 | N/A |
| TOTAL | $37,388 | $31,297 | $23,953 | $24,200 | $17,709 |
| Non-Current Liabilities | |||||
| Long Term Debt | 256,946 | 254,428 | 250,474 | 260,728 | 228,959 |
| Other Non-Current Liabilities | 49,246 | 25,931 | 4,686 | 5,798 | 5,946 |
| TOTAL | $306,192 | $280,359 | $255,160 | $266,526 | $234,905 |
| Total Liabilities | $343,580 | $311,656 | $279,113 | $290,726 | $252,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,265 | 52,366 | 46,893 | 42,219 | 32,416 |
| Common Shares | 56 | 52 | 46 | 40 | 32 |
| Retained earnings | -930,449 | -866,883 | -807,799 | -711,258 | -582,468 |
| Other shareholders' equity | 0 | -9 | 4 | 74 | -128 |
| TOTAL | $-171,042 | $-127,787 | $-102,260 | $-39,647 | $47,578 |
| Total Liabilities And Equity | $172,538 | $183,869 | $176,853 | $251,079 | $300,192 |